(NYSE: NVST) Envista Holdings's forecast annual revenue growth rate of 3.07% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.79%.
Envista Holdings's revenue in 2025 is $2,552,900,000.On average, 6 Wall Street analysts forecast NVST's revenue for 2025 to be $435,709,192,760, with the lowest NVST revenue forecast at $430,144,764,048, and the highest NVST revenue forecast at $438,011,972,855. On average, 6 Wall Street analysts forecast NVST's revenue for 2026 to be $449,501,278,430, with the lowest NVST revenue forecast at $438,563,696,165, and the highest NVST revenue forecast at $455,404,385,488.
In 2027, NVST is forecast to generate $464,834,367,189 in revenue, with the lowest revenue forecast at $452,614,360,591 and the highest revenue forecast at $471,557,248,672.